Banks - Regional
Build Your Comparison
Side-by-side financial analysisStock Comparison
BOTJ vs MNSB vs CARE vs FXNC
Revenue, margins, valuation, and 5-year total return — side by side.
Banks - Regional
Banks - Regional
Banks - Regional
BOTJ vs MNSB vs CARE vs FXNC — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||||
|---|---|---|---|---|
| Industry | Banks - Regional | Banks - Regional | Banks - Regional | Banks - Regional |
| Market Cap | $112M | $184M | $662M | $273M |
| Revenue (TTM) | $62M | $135M | $252M | $115M |
| Net Income (TTM) | $9M | $16M | $31M | $18M |
| Gross Margin | 77.7% | 54.3% | 61.2% | 74.7% |
| Operating Margin | 18.0% | 14.1% | 15.9% | 19.0% |
| Forward P/E | 12.4x | 11.0x | 5.5x | 12.8x |
| Total Debt | $9M | $70M | $179M | $43M |
| Cash & Equiv. | $29M | $26M | $105M | $161M |
BOTJ vs MNSB vs CARE vs FXNC — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Jun 20 | Jun 26 | Return |
|---|---|---|---|
| Bank of the James F… (BOTJ) | 100 | 288.2 | +188.2% |
| MainStreet Bancshar… (MNSB) | 100 | 188.9 | +88.9% |
| Carter Bankshares, … (CARE) | 100 | 370.2 | +270.2% |
| First National Corp… (FXNC) | 100 | 217.5 | +117.5% |
Price return only. Dividends and distributions are not included.
Quick Verdict: BOTJ vs MNSB vs CARE vs FXNC
Each card shows where this stock fits in a portfolio — not just who wins on paper.
BOTJ has the current edge in this matchup, primarily because of its strength in sleep-well-at-night and valuation efficiency.
- Lower volatility, beta 0.15, Low D/E 11.0%, current ratio 496.36x
- PEG 0.90 vs FXNC's 8.59
- Beta 0.15, yield 1.6%, current ratio 496.36x
- Lower P/E (12.4x vs 12.8x), PEG 0.90 vs 8.59
MNSB is the #2 pick in this set and the best alternative if quality and efficiency is your priority.
- Efficiency ratio 0.4% vs BOTJ's 0.6% (lower = leaner)
- Efficiency ratio 0.4% vs BOTJ's 0.6%
CARE is the clearest fit if your priority is momentum.
- +79.6% vs MNSB's +37.2%
FXNC is the clearest fit if your priority is income & stability and growth exposure.
- Dividend streak 11 yrs, beta 0.52, yield 2.0%
- Rev growth 27.1%, EPS growth 96.0%
- 258.5% 10Y total return vs CARE's 141.7%
- NIM 3.6% vs CARE's 2.7%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 27.1% NII/revenue growth vs MNSB's -1.4% | |
| Value | Lower P/E (12.4x vs 12.8x), PEG 0.90 vs 8.59 | |
| Quality / Margins | Efficiency ratio 0.4% vs BOTJ's 0.6% (lower = leaner) | |
| Stability / Safety | Beta 0.15 vs MNSB's 0.60, lower leverage | |
| Dividends | 2.0% yield, 11-year raise streak, vs BOTJ's 1.6%, (1 stock pays no dividend) | |
| Momentum (1Y) | +79.6% vs MNSB's +37.2% | |
| Efficiency (ROA) | Efficiency ratio 0.4% vs BOTJ's 0.6% |
BOTJ vs MNSB vs CARE vs FXNC — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
BOTJ vs MNSB vs CARE vs FXNC — Financial Metrics
Side-by-side numbers across 4 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
FXNC leads in 2 of 6 categories
BOTJ leads 2 • CARE leads 1 • MNSB leads 0 • 1 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
FXNC leads this category, winning 4 of 5 comparable metrics.
Income & Cash Flow (Last 12 Months)
CARE is the larger business by revenue, generating $252M annually — 4.1x BOTJ's $62M. Profitability is closely matched — net margins range from 15.4% (FXNC) to 11.5% (MNSB).
| Metric | ||||
|---|---|---|---|---|
| RevenueTrailing 12 months | $62M | $135M | $252M | $115M |
| EBITDAEarnings before interest/tax | $12M | $23M | $46M | $25M |
| Net IncomeAfter-tax profit | $9M | $16M | $31M | $18M |
| Free Cash FlowCash after capex | $10M | $11M | $30M | $21M |
| Gross MarginGross profit ÷ Revenue | +77.7% | +54.3% | +61.2% | +74.7% |
| Operating MarginEBIT ÷ Revenue | +18.0% | +14.1% | +15.9% | +19.0% |
| Net MarginNet income ÷ Revenue | +14.6% | +11.5% | +12.5% | +15.4% |
| FCF MarginFCF ÷ Revenue | +16.6% | +7.9% | +11.9% | +18.2% |
| Rev. Growth (YoY)Latest quarter vs prior year | — | — | — | — |
| EPS Growth (YoY)Latest quarter vs prior year | +66.7% | +120.9% | +8.3% | +7.1% |
Valuation Metrics
BOTJ leads this category, winning 3 of 7 comparable metrics.
Valuation Metrics
At 12.4x trailing earnings, BOTJ trades at a 42% valuation discount to CARE's 21.3x P/E. Adjusting for growth (PEG ratio), BOTJ offers better value at 0.90x vs FXNC's 10.32x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | ||||
|---|---|---|---|---|
| Market CapShares × price | $112M | $184M | $662M | $273M |
| Enterprise ValueMkt cap + debt − cash | $93M | $227M | $735M | $155M |
| Trailing P/EPrice ÷ TTM EPS | 12.44x | 14.16x | 21.34x | 15.40x |
| Forward P/EPrice ÷ next-FY EPS est. | — | 11.03x | 5.47x | 12.82x |
| PEG RatioP/E ÷ EPS growth rate | 0.90x | — | — | 10.32x |
| EV / EBITDAEnterprise value multiple | 7.44x | 11.90x | 18.38x | 7.05x |
| Price / SalesMarket cap ÷ Revenue | 1.80x | 1.35x | 2.60x | 2.43x |
| Price / BookPrice ÷ Book value/share | 1.41x | 0.87x | 1.60x | 1.46x |
| Price / FCFMarket cap ÷ FCF | 10.72x | 17.26x | 20.81x | 12.99x |
Profitability & Efficiency
BOTJ leads this category, winning 5 of 9 comparable metrics.
Profitability & Efficiency
BOTJ delivers a 12.1% return on equity — every $100 of shareholder capital generates $12 in annual profit, vs $7 for MNSB. BOTJ carries lower financial leverage with a 0.11x debt-to-equity ratio, signaling a more conservative balance sheet compared to CARE's 0.43x. On the Piotroski fundamental quality scale (0–9), CARE scores 8/9 vs MNSB's 5/9, reflecting strong financial health.
| Metric | ||||
|---|---|---|---|---|
| ROE (TTM)Return on equity | +12.1% | +7.3% | +7.6% | +10.0% |
| ROA (TTM)Return on assets | +0.9% | +0.7% | +0.7% | +0.9% |
| ROICReturn on invested capital | +9.7% | +5.0% | +5.7% | +7.7% |
| ROCEReturn on capital employed | +2.0% | +6.0% | +1.5% | +9.9% |
| Piotroski ScoreFundamental quality 0–9 | 7 | 5 | 8 | 7 |
| Debt / EquityFinancial leverage | 0.11x | 0.32x | 0.43x | 0.23x |
| Net DebtTotal debt minus cash | -$20M | $43M | $73M | -$118M |
| Cash & Equiv.Liquid assets | $29M | $26M | $105M | $161M |
| Total DebtShort + long-term debt | $9M | $70M | $179M | $43M |
| Interest CoverageEBIT ÷ Interest expense | 0.80x | 0.31x | 0.39x | 0.84x |
Total Returns (Dividends Reinvested)
CARE leads this category, winning 3 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in CARE five years ago would be worth $20,802 today (with dividends reinvested), compared to $11,813 for MNSB. Over the past 12 months, CARE leads with a +79.6% total return vs MNSB's +37.2%. The 3-year compound annual growth rate (CAGR) favors BOTJ at 42.8% vs MNSB's 4.2% — a key indicator of consistent wealth creation.
| Metric | ||||
|---|---|---|---|---|
| YTD ReturnYear-to-date | +34.6% | +26.5% | +54.3% | +24.4% |
| 1-Year ReturnPast 12 months | +75.9% | +37.2% | +79.6% | +57.8% |
| 3-Year ReturnCumulative with dividends | +191.2% | +13.1% | +93.9% | +103.7% |
| 5-Year ReturnCumulative with dividends | +55.8% | +18.1% | +108.0% | +71.0% |
| 10-Year ReturnCumulative with dividends | +155.2% | +135.4% | +141.7% | +258.5% |
| CAGR (3Y)Annualised 3-year return | +42.8% | +4.2% | +24.7% | +26.8% |
Risk & Volatility
Evenly matched — BOTJ and CARE each lead in 1 of 2 comparable metrics.
Risk & Volatility
BOTJ is the less volatile stock with a 0.15 beta — it tends to amplify market swings less than MNSB's 0.60 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. CARE currently trades 99.6% from its 52-week high vs BOTJ's 93.5% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||||
|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.15x | 0.60x | 0.58x | 0.52x |
| 52-Week HighHighest price in past year | $26.49 | $25.17 | $29.99 | $30.51 |
| 52-Week LowLowest price in past year | $13.00 | $17.86 | $16.14 | $18.31 |
| % of 52W HighCurrent price vs 52-week peak | +93.5% | +99.0% | +99.6% | +99.0% |
| RSI (14)Momentum oscillator 0–100 | 72.9 | 65.3 | 72.8 | 67.0 |
| Avg Volume (50D)Average daily shares traded | 14K | 45K | 316K | 79K |
Analyst Outlook
FXNC leads this category, winning 2 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: MNSB as "Hold", CARE as "Hold", FXNC as "Buy". Consensus price targets imply -4.6% upside for CARE (target: $29) vs -30.4% for FXNC (target: $21). For income investors, FXNC offers the higher dividend yield at 2.03% vs MNSB's 1.60%.
| Metric | ||||
|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | Hold | Hold | Buy |
| Price TargetConsensus 12-month target | — | — | $28.50 | $21.00 |
| # AnalystsCovering analysts | — | 1 | 5 | 1 |
| Dividend YieldAnnual dividend ÷ price | +1.6% | +1.6% | — | +2.0% |
| Dividend StreakConsecutive years of raises | 0 | 0 | 0 | 11 |
| Dividend / ShareAnnual DPS | $0.40 | $0.40 | — | $0.61 |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | +2.4% | +3.0% | +0.1% |
FXNC leads in 2 of 6 categories (Income & Cash Flow, Analyst Outlook). BOTJ leads in 2 (Valuation Metrics, Profitability & Efficiency). 1 tied.
BOTJ vs MNSB vs CARE vs FXNC: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is BOTJ or MNSB or CARE or FXNC a better buy right now?
For growth investors, First National Corporation (FXNC) is the stronger pick with 27.
1% revenue growth year-over-year, versus -1. 4% for MainStreet Bancshares, Inc. (MNSB). Bank of the James Financial Group, Inc. (BOTJ) offers the better valuation at 12. 4x trailing P/E, making it the more compelling value choice. Analysts rate First National Corporation (FXNC) a "Buy" — based on 1 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — BOTJ or MNSB or CARE or FXNC?
On trailing P/E, Bank of the James Financial Group, Inc.
(BOTJ) is the cheapest at 12. 4x versus Carter Bankshares, Inc. at 21. 3x. On forward P/E, Carter Bankshares, Inc. is actually cheaper at 5. 5x — notably different from the trailing picture, reflecting expected earnings growth.
03Which is the better long-term investment — BOTJ or MNSB or CARE or FXNC?
Over the past 5 years, Carter Bankshares, Inc.
(CARE) delivered a total return of +108. 0%, compared to +18. 1% for MainStreet Bancshares, Inc. (MNSB). Over 10 years, the gap is even starker: FXNC returned +258. 5% versus MNSB's +135. 4%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — BOTJ or MNSB or CARE or FXNC?
By beta (market sensitivity over 5 years), Bank of the James Financial Group, Inc.
(BOTJ) is the lower-risk stock at 0. 15β versus MainStreet Bancshares, Inc. 's 0. 60β — meaning MNSB is approximately 287% more volatile than BOTJ relative to the S&P 500. On balance sheet safety, Bank of the James Financial Group, Inc. (BOTJ) carries a lower debt/equity ratio of 11% versus 43% for Carter Bankshares, Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — BOTJ or MNSB or CARE or FXNC?
By revenue growth (latest reported year), First National Corporation (FXNC) is pulling ahead at 27.
1% versus -1. 4% for MainStreet Bancshares, Inc. (MNSB). On earnings-per-share growth, the picture is similar: MainStreet Bancshares, Inc. grew EPS 210. 0% year-over-year, compared to 13. 7% for Bank of the James Financial Group, Inc.. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — BOTJ or MNSB or CARE or FXNC?
First National Corporation (FXNC) is the more profitable company, earning 15.
8% net margin versus 11. 5% for MainStreet Bancshares, Inc. — meaning it keeps 15. 8% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: FXNC leads at 19. 6% versus 14. 0% for MNSB. At the gross margin level — before operating expenses — BOTJ leads at 77. 9%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is BOTJ or MNSB or CARE or FXNC more undervalued right now?
On forward earnings alone, Carter Bankshares, Inc.
(CARE) trades at 5. 5x forward P/E versus 12. 8x for First National Corporation — 7. 3x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for CARE: -4. 6% to $28. 50.
08Which pays a better dividend — BOTJ or MNSB or CARE or FXNC?
In this comparison, FXNC (2.
0% yield), BOTJ (1. 6% yield), MNSB (1. 6% yield) pay a dividend. CARE does not pay a meaningful dividend and should not be held primarily for income.
09Is BOTJ or MNSB or CARE or FXNC better for a retirement portfolio?
For long-horizon retirement investors, Bank of the James Financial Group, Inc.
(BOTJ) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 15), 1. 6% yield, +155. 2% 10Y return). Both have compounded well over 10 years (BOTJ: +155. 2%, CARE: +141. 7%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between BOTJ and MNSB and CARE and FXNC?
Both stocks operate in the Financial Services sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: BOTJ is a small-cap deep-value stock; MNSB is a small-cap deep-value stock; CARE is a small-cap quality compounder stock; FXNC is a small-cap high-growth stock. BOTJ, MNSB, FXNC pay a dividend while CARE does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.